Pages that link to "Q33989047"
Jump to navigation
Jump to search
The following pages link to Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study (Q33989047):
Displaying 50 items.
- Life expectancy of HIV-positive adults: a review (Q22248095) (← links)
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies (Q24597052) (← links)
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies (Q24656950) (← links)
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS (Q24685909) (← links)
- Effective coverage: a metric for monitoring Universal Health Coverage (Q26823075) (← links)
- Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model (Q26852432) (← links)
- Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure (Q28469116) (← links)
- Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection (Q28478934) (← links)
- Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study (Q28534423) (← links)
- Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan (Q28537608) (← links)
- Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan (Q28541867) (← links)
- Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy (Q28547874) (← links)
- Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada (Q28610686) (← links)
- Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy (Q28730448) (← links)
- Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis (Q28742423) (← links)
- Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection (Q28749594) (← links)
- Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator (Q28749656) (← links)
- HIV-1 Genetic Variability and Clinical Implications (Q30352010) (← links)
- Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study (Q30570107) (← links)
- HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011. (Q30679531) (← links)
- A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort. (Q30700708) (← links)
- From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany (Q30925594) (← links)
- Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort (Q33267347) (← links)
- Analysis of treatment effectiveness in longitudinal observational data (Q33299846) (← links)
- Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda (Q33385849) (← links)
- The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain (Q33424079) (← links)
- Prediction and treatment of asthma in preschool children at risk: study design and baseline data of a prospective cohort study in general practice (ARCADE). (Q33430476) (← links)
- Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV. (Q33477968) (← links)
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals (Q33505475) (← links)
- Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death (Q33566815) (← links)
- Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters (Q33585427) (← links)
- Antibody responses to lytic and latent human herpesvirus 8 antigens among HIV-infected patients in central China (Q33593814) (← links)
- Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study (Q33609257) (← links)
- Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation (Q33622913) (← links)
- Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making (Q33626699) (← links)
- Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies (Q33638209) (← links)
- Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV (Q33703513) (← links)
- Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012. (Q33713778) (← links)
- A comparison of perioperative outcomes of video-assisted thoracic surgical (VATS) lobectomy with open thoracotomy and lobectomy: results of an analysis using propensity score based weighting (Q33766152) (← links)
- Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study (Q33816071) (← links)
- Mortality after failure of antiretroviral therapy in sub-Saharan Africa (Q33862806) (← links)
- When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study (Q33876261) (← links)
- Time scale and adjusted survival curves for marginal structural cox models (Q33880815) (← links)
- Mortality by causes in HIV-infected adults: comparison with the general population. (Q33898621) (← links)
- A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1 (Q33927293) (← links)
- Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study (Q33951598) (← links)
- Analyzing direct and indirect effects of treatment using dynamic path analysis applied to data from the Swiss HIV Cohort Study (Q33975107) (← links)
- Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions (Q33980117) (← links)
- Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study (Q34011661) (← links)
- Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling (Q34123283) (← links)